LGC acquires Douglas Scientific to expand its high-throughput PCR platform offering

News (ZH) - LGC announces that it has acquired a majority stake in Douglas Scientific

LGC acquires Biosearch Technologies and extends its expertise in the qPCR market

News (ZH) - Acquisition enables enlarged Genomics division to deliver unique product and laboratory services offering for core qPCR and end point PCR applications

Meridian2 delivers high throughput liquid handling for PCR

News (ZH) - Next generation liquid dispensing system integrates with existing SNPline automation or other Meridian instruments

Hydrocycler2 delivers high throughput thermal cycling for PCR

News (ZH) - Innovative genomics solution addresses issues of increasing throughput and achieving high data quality

Horizon Discovery and LGC awarded Technology Strategy Board grant to develop standardization for next generation cancer diagnostics

News (ZH) - Project funds research and development of novel reference materials to serve clinical diagnostics

We have just completed one Billion KASP genotyping PCRs!

News (ZH) - Winners of our Billionth PCR competition include groups from all over the world.

LGC a key player in industry-influencing PCR guidelines

News (ZH) - MIQE guidelines help transparency and reporting of technical details necessary for high-quality, reproducible results

LGC and customers expediting coronavirus diagnostic solutions

News (ZH) - Working closely with customers to ensure mission-critical oligo chemistries, controls and components for detection kits are available where and when necessary

New £1.3 million national research programme to evaluate coronavirus tests in hospitals, GP surgeries and care homes

News (ZH) - Research programme brings together experts who are highly experienced in evaluating diagnostic tests and generating robust evidence required for a test to be used in the NHS

LGC’s high-throughput PCR testing system for SARS-CoV-2 detection granted Emergency Use Authorisation

News (ZH) - Authorisation enables qualified laboratories to address SARS-CoV-2 testing demands while providing significant economic advantage when compared to other technologies